Recent trials of monoclonal antibodies in patients with leukemias or lymphomas have demonstrated the remarkable potency of these agents to kill tumor cells specifically and safely. New molecular biological and radiochemical techniques are also allowing rapid inroads into the remaining obstacles to t
The promise of monoclonal antibodies for the therapy of cancer
โ Scribed by John Gutheil
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 51 KB
- Volume
- 38
- Category
- Article
- ISSN
- 1040-8428
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Recent advances utilizing monoclonal antibodies to phenotype acute leukemias have revealed no prognostic significance of the expression of lymphoid-associated antigens by acute myeloid leukemia blasts and conflicting results regarding 'biphenotypic' acute myeloid leukemia. Several studies treating p
## Abstract Psoriasis is a common skin disorder characterized by erythematous, scaling plaques. Until recently, therapies for this disease have been aimed at reducing keratinocyte proliferation. We have learned that psoriasis is not primarily a disorder of keratinocyte hyperproliferation, but is an